Literature DB >> 2926131

Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations.

Y Imai1, K Abe, S Sasaki, N Minami, M Munakata, M Nihei, H Sekino, K Yoshinaga.   

Abstract

The effect of glucocorticoid on circadian variations of blood pressure was examined. In untreated patients with essential hypertension, a clear nocturnal fall in blood pressure and heart rate was observed and this was unaffected by combined treatment with antihypertensive drugs. The circadian blood pressure variation in patients with chronic glomerulonephritis (CGN) not receiving glucocorticoid treatment was essentially the same as that in patients with essential hypertension. In both groups there was a positive correlation between blood pressure and heart rate. On the other hand, in patients with CGN and systemic lupus erythematosus (SLE) who were treated with glucocorticoid, there was no nocturnal fall in blood pressure, and often a significant rise. In these patients the blood pressure was lowest in the afternoon and began to rise from then, and during the night, attaining a peak level in the morning. Despite this changed pattern of blood pressure variations, the heart rate in these patients was clearly reduced at night. In 10 patients with CGN and SLE, circadian rhythm of blood pressure and heart rate was examined before and during treatment with prednisolone (40.2 +/- 17.0 mg/day for 58.0 +/- 19.4 days, mean +/- s.d.). Prednisolone abolished the nocturnal fall of blood pressure, while the nocturnal fall of heart rate remained. There was no correlation between blood pressure and heart rate in patients with glucocorticoid treatment. These results suggest that the circadian blood pressure variation is influenced by the hypothalamo-pituitary-adrenal axis, probably through its action on the autonomic nervous system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2926131

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  16 in total

1.  Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment.

Authors:  S Zacharieva; M Orbetzova; A Stoynev; R Shigarminova; M Yaneva; K Kalinov; E Nachev; A Elenkova
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

Review 2.  Glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; David S Geller
Journal:  Pediatr Nephrol       Date:  2011-07-09       Impact factor: 3.714

3.  Description of a new quotient that may differentiate blood pressure profiles in essential versus Cushing's syndrome-related hypertension.

Authors:  P Stiefel; J Gimenez; M L Miranda; A Leal-Cerro; O Muñiz; E Pamies; V Martín-Sanz; J Villar; J Carneado
Journal:  J Endocrinol Invest       Date:  1995-11       Impact factor: 4.256

4.  Cushing's syndrome: all variants, detection, and treatment.

Authors:  Susmeeta T Sharma; Lynnette K Nieman
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

5.  Higher Frequency of Nocturnal Blood Pressure Dipping but Not Heart Rate Dipping in Inflammatory Bowel Disease.

Authors:  Leili Pourafkari; Kourosh Masnadi-Shirazi; Mohammadreza Taban; Solmaz Mohammadi; Razieh Parizad; Samad Ghaffari; Arezou Tajlil; Mir Milad Pourmousavi Khoshknab; Nader D Nader
Journal:  Dig Dis Sci       Date:  2017-08-23       Impact factor: 3.199

Review 6.  Cyclosporin-induced hypertension: incidence, pathogenesis and management.

Authors:  S J Taler; S C Textor; V J Canzanello; L Schwartz
Journal:  Drug Saf       Date:  1999-05       Impact factor: 5.606

Review 7.  A personal history of research on hypertension From an encounter with hypertension to the development of hypertension practice based on out-of-clinic blood pressure measurements.

Authors:  Yutaka Imai
Journal:  Hypertens Res       Date:  2022-09-08       Impact factor: 5.528

8.  Determinants of daytime blood pressure in relation to obstructive sleep apnea in men.

Authors:  Jamie C M Lam; Clara S W Yan; Agnes Y K Lai; Sidney Tam; Daniel Y T Fong; Bing Lam; Mary S M Ip
Journal:  Lung       Date:  2009-08-05       Impact factor: 2.584

Review 9.  Clinical uses of ambulatory blood pressure monitoring.

Authors:  R J Portman; R J Yetman
Journal:  Pediatr Nephrol       Date:  1994-06       Impact factor: 3.714

10.  High frequency of nocturnal hypertension in lupus nephritis: should ABPM be implemented in usual practice?

Authors:  Juan M Mejia-Vilet; Yesser J López-Hernández; Mariedel Trujeque-Matos; J Iván Santander-Velez; Mayra L Cano-Verduzco; Cristino Cruz; Luis E Morales-Buenrostro
Journal:  Clin Rheumatol       Date:  2019-12-14       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.